The Deal
Sunday, November 8, 
9:43 am

Nestle should chew on this

  Share     E-Mail    Discussion    Print Story

Executives at Beech-Nut Nutrition Corp. and H.J. Heinz Co. must have an interesting take on Nestlé SA's $5.5 billion deal for Gerber. As regulation wonks will recall, Beech-Nut and Heinz fought a landmark 2001 antitrust battle (remember those?) with the Federal Trade Commission, which the previous year had blocked the ketchup company's $180 million deal for Beech-Nut. After losing the “baby food” case, as it came to be called, in district court, the FTC took the fight to appellate court, which affirmed the agency's argument that the merger would reduce competition for baby food by effectively creating a duopoly consisting of Gerber and a merged Heinz and Beech-Nut. At the time, FTC antirust chief Robert Pitofsky called the ruling one of the most important of his tenure. "If the court began to allow 3-to-2 mergers in these circumstances, the likely consumer harm would be enormous," he said six years ago.

With Gerber, Nestlé will have roughly 79% of the baby food market. Any antitrust issues here? Nope. Gerber is the dominant maker of jarred baby food; Nestle's not, which suggests that the merger won't hurt competition. Of course, in taking on Nestle, Heinz and Beech-Nut will now face a corporate juggernaut in producing turkey purée and other tasty treats for the world's infants. The companies could conceivably argue that, in view of changing market dynamics, they need to merge more than ever to remain competitive. Might such reasoning fly today at an FTC that has proved markedly averse to challenging deals? Doubtful. A strong presumption remains among regulators and antitrust lawyers that so-called 3-to-2 deals harm consumers.—Alain Sherter

See Gerber story from TheDeal.com
See 2001 Beech-Nut story from TheDeal.com
See Pitofsky story from TheDeal.com
See related post from Dealscape

Continue reading below

Also on Dealscape





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.